4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000049
President and CEO sold 36,916 shares at an average $20.34 ($750,955)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-06 | Sale : show line 1 in the form | −29,266 | $20.22 | $591,759 | 260,721 | D |
| 2025-01-07 | Sale : show line 2 in the form | −7,650 | $20.81 | $159,197 | 253,071 | D |
| Open-market sales · 36,916 sh · avg $20.34 · $750,955 | ||||||
Loading xslF345X05/wk-form4_1736385877.xml…